Skip to content
Investing

Investing Cash Flow

Guardant Health Investing Cash Flow increased by 177.3% to $699.42M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 130.9%, from $302.86M to $699.42M.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026May 7, 2026

How to read this metric

Negative values typically reflect heavy investment in growth, while positive values may indicate divestment or the maturity of investment portfolios.

Detailed definition

This is the net result of all cash inflows and outflows related to the acquisition and disposal of long-term assets and...

Peer comparison

Usually negative for growth-stage biotech companies investing in infrastructure and R&D.

Metric ID: net_cash_from_investing

Historical Data

15 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q3 '24Q1 '25Q4 '25Q1 '26
Value$127.07M-$47.39M-$266.7M$110.81M$41.27M$70.63M$157.22M-$241.13M$260.7M$663.45M$28.07M-$294.83M$302.86M-$905.07M$699.42M
QoQ Change-137.3%-462.7%+141.5%-62.8%+71.1%+122.6%-253.4%+208.1%+154.5%-95.8%<-999%+202.7%-398.8%+177.3%
YoY Change+187.1%+126.5%+41.9%+531.6%+839.4%-82.1%-213.1%+979.1%+130.9%
Range-$905.07M$699.42M
CAGR+62.8%
Avg YoY Growth+282.4%
Median YoY Growth+130.9%

Frequently Asked Questions

What is Guardant Health's investing cash flow?
Guardant Health (GH) reported investing cash flow of $699.42M in Q1 2026.
How has Guardant Health's investing cash flow changed year-over-year?
Guardant Health's investing cash flow increased by 130.9% year-over-year, from $302.86M to $699.42M.
What does investing cash flow mean?
The net amount of cash spent on or generated from investments and long-term assets.